[Hormone therapy and risk for venous thromboembolism in postmenopausal women]. - Université de Bretagne Occidentale Access content directly
Journal Articles Revue du Praticien (La) Year : 2005

[Hormone therapy and risk for venous thromboembolism in postmenopausal women].

Abstract

Oral estrogens are associated with a two-fold to three-fold increased risk of venous thromboembolism in postmenopausal women. Absolute excess risk is low but higher than for contraceptive pills. Biological data and observational studies suggest that transdermal estrogens are associated with a lower risk for venous thromboembolism than oral estrogens but safety has yet to be proved. Whether addition of progestin plays a significant role is undetermined so far.
No file

Dates and versions

hal-00722073 , version 1 (31-07-2012)

Identifiers

  • HAL Id : hal-00722073 , version 1
  • PUBMED : 15828617

Cite

Karine Lacut, Emmanuel Oger. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].. Revue du Praticien (La), 2005, 55 (4), pp.389-92. ⟨hal-00722073⟩
29 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More